InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by McClellan William D. Jr., Director. Director active across 3 companies, notably Apollo Endosurgery, Inc.. In total, 6 filings have been published. The latest transaction was disclosed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations6 total
014,224 shares0
Common Stock
SEC:0001251769-22-000056:0·
€9,308287 shares@ €32.432576.7% of flow
Class A common stock
SEC:0001209191-22-035412:0·
€1,41759 shares@ €24.0208100.0% of flow
Class A common stock
SEC:0001209191-22-001625·
€1,41759 shares@ €24.020811.7% of flow
Class A common stock
SEC:0001209191-22-001625:0·
03,888 shares0
Common Stock
SEC:0001251769-21-000085·
03,888 shares0
Common Stock
SEC:0001251769-21-000085:0·
6 of 6 declarations
About McClellan William D. Jr.
William D. McClellan Jr. is a Board Member at Apollo Endosurgery, Inc. and REATA PHARMACEUTICALS INC. He has extensive experience in the medical devices and biopharmaceutical sectors. As a Board Member, he oversees growth and innovation strategies for these companies.
